POAI
Predictive Oncology Inc. · Healthcare
5.45
28.24%(+1.20)
Market OpenLast Updated: — ET
52W L: $1.2152W H: $45.90
$5.45
CHG+3.57 (+189.89%)
H$6.38
L$1.06
VOL10M
POAI (1h)
Predictive Oncology Inc. · Healthcare
Axe Compute (NASDAQ: AGPU) used its fiscal year 2025 investor presentation to outline its transition toward a GPU compute capacity platform, discuss early commercial traction following its rebrand, and walk investors through financial results that management said were heavily influenced by non-cash accounting impacts tied to digital assets and derivatives. Leadership changes and strategic direction Christopher
Predictive Oncology Inc. (NASDAQ: POAI - Get Free Report)'s stock price crossed below its two hundred day moving average during trading on Wednesday. The stock has a two hundred day moving average of $7.41 and traded as low as $1.54. Predictive Oncology shares last traded at $1.57, with a volume of 34,209 shares changing hands.
Predictive Oncology (NASDAQ: POAI - Get Free Report) and Mitesco (OTCMKTS:MITI - Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, profitability, earnings, analyst recommendations, institutional ownership and dividends. Analyst Ratings This is a breakdown of current
Healthcare Triangle (NASDAQ: HCTI - Get Free Report) and Predictive Oncology (NASDAQ: POAI - Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, risk, profitability, institutional ownership, earnings and dividends. Analyst Recommendations This is a summary of
Predictive Oncology Inc. (NASDAQ: POAI - Get Free Report) shares passed below its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $10.47 and traded as low as $6.52. Predictive Oncology shares last traded at $6.7596, with a volume of 40,332 shares changing hands. Analyst Upgrades and Downgrades A
No recent filings